Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial.

Hitoshi TsudaMasafumi KurosumiFutoshi AkiyamaShinji OhnoShigehira SajiNorikazu MasudaAkihiko ShimomuraNobuaki SatoShintaro TakaoShozo OhsumiYutaka TokudaHideo InajiToru Watanabe

Published in: Breast cancer (Tokyo, Japan) (2022)

UMIN000022571. Date of registration: June 1, 2016.

Keyphrases

lymph node
phase iii
study protocol
phase ii
clinical trial
prognostic factors
open label
randomized controlled trial